Cystatin 6 (CST6) and Legumain (LGMN) are potential mediators in the pathogenesis of preeclampsia

Abstract Preeclampsia results from placental insufficiency and causes maternal endothelial dysfunction and multi-organ damage. Our in-silico analysis identified Cystatin 6 (CST6), a cysteine protease inhibitor, as located on the placental surface where it might be released into maternal circulation....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Scientific Reports
Main Authors: Stefan M. Botha, Lucy A. Bartho, Sunhild Hartmann, Ping Cannon, Anna Nguyen, Tuong-Vi Nguyen, Natasha Pritchard, Ralf Dechend, Olivia Nonn, Stephen Tong, Tu’uhevaha J. Kaitu’u-Lino
Formato: Artigo
Publicado em: Nature Portfolio 2025-04-01
Assuntos:
Cystatin 6
CST6
Legumain
LGMN
Pregnancy
Preeclampsia
Acesso em linha:https://doi.org/10.1038/s41598-025-96823-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Internet

https://doi.org/10.1038/s41598-025-96823-9

Registos relacionados